Using Hi-C, genome sequencing, and optical mapping, researchers profiled structural variants in multiple cancer cell lines, leading to potential non-coding drivers.
The company hopes to develop saliva-based RNA assays for concussion, Parkinson's disease and autism using biomarkers discovered by its two academic partners.
Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.
VISION aims to provide validated regulatory modules, quantitative models for gene regulation, and guides for translating research from mouse models to human.
By sequencing ancient and contemporary indigenous individuals from Canada's Pacific Coast, researchers uncovered clues to a post-colonization population bottleneck.
Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.
